Cardiac IVD Company Critical Diagnostics Expands Its Global Presence


Cardiac IVD Company Critical Diagnostics Expands Its Global Presence

Several distribution deals double the EU market for the Presage® ST2 Assay

SAN DIEGO--(BUSINESS WIRE)-- Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, and makers of the Presage® ST2 Assay, today announced several new European distribution deals. The Company has chosen as exclusive distributors (in alphabetical order), Assut Europe in Italy and San Marino, Biochemmack in Russia, Cruinn Diagnostics in Ireland, IVD Bulgaria in Bulgaria, Life Biomedical in the UK, Maritim Ltd. In Slovenia, Croatia and Serbia, Nordic Diagnostica in Sweden, and Sopachem in Benelux.

"In addition to established distributor relationships in France, Germany and Spain, Portugal and Turkey, these new partnerships continue to broaden our presence across Europe," notes Richard Hughes, Vice President, Business Development Europe for Critical Diagnostics. "With our extensive network of distributor partners all across the Asia Pacific region, we are truly a global company, prepared to meet the needs of the 23 million heart failure patients that suffer from this serious disease."

About Assut Europe

Headquartered in Rome, Assut Europe, with strengths in medical devices and biomedical systems, has manufacturing and sales operations across Europe and beyond. ST2 is the first in a line of novel diagnostic products to be integrated into this new venture for Assut.

About Biochemmack

Russian distributor Biochemmack have been actively supporting the Russian diagnostic business since the late 1980's. With a large geography and population, Russia is fast becoming a leading healthcare market and Biochemmack are well placed to take advantage of this. They have expertise in the fields of Cardiology and new biomarker launch, so are fully prepared to make ST2 a success in Russia.

About Cruinn Diagnostics

Cruinn are a Dublin based distributor of diagnostic reagents who have been in business since 1998, supplying a broad spectrum of healthcare diagnostics across a range of healthcare customers.

About IVD Bulgaria

IVD Bulgaria is a Medical Devices and Equipment distributor company, based in Sofia. Established in 2008, the company offers a broad range of products in the field of IVD, IVF and Life Science, and experts in the field of ELISA and novel markers.

About Life Biomedical

Headquartered in the world famous Babraham Institute in Cambridge, England, Life Biomedical are a relatively young company in the field of in-vitro diagnostics, with the aim to distribute innovative, high quality products that will maximize new research discovery and improve patient care.

About Maritim Ltd.

Maritim Ltd. based in Lublijana, Slovenia have been in the IVD business for over two decades. Their highly-experience staff covers Slovenia, Serbia and Croatia.

About Nordic Diagnostica

Nordic Diagnostics are a relatively young company having been created from Dia Service in 2009. They specialize in novel biomarkers and niche healthcare markets, making them the perfect partner for Critical Diagnostics as we expand into Scandinavia

About Sopachem

Sopachem have offices in Belgium and the Netherlands and are specialists in life sciences and innovation in healthcare. Their track record with new biomarkers is exemplary and we are keen to help them add ST2 to their very successful portfolio.

About ST2

Soluble ST2 has now been published in more than 100 peer-reviewed articles and scientific posters studying more than 40,000 patients. These clinical studies have demonstrated that high levels of soluble ST2 are predictive of adverse patient outcomes and death in a broad spectrum of cardiovascular disease. They have further shown that the prognostic information from soluble ST2 is independent of, and provides added information to, that of cardiac biomarkers commonly used today. The Presage ST2 Assay has been CE Marked and cleared by the U.S. FDA.

About Critical Diagnostics

Critical Diagnostics ( develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs.

Critical Diagnostics
Dennis Dalangin, 877-700-1250
VP Marketing

KEYWORDS: United States North America California


The article Cardiac IVD Company Critical Diagnostics Expands Its Global Presence originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.